EDAP TMS (EDAP) Stock Price, News & Analysis

Company Overview

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology. The UDS segment focuses on the development, marketing, manufacturing, and servicing of medical devices for the minimally invasive diagnosis or treatment of urological disorders, mainly urinary stones, and other clinical indications. The company was founded on December 3, 1979 and is headquartered in Vaulx-en-Velin, France.

Key Stats

• Today's Range: $1.60 to $1.71
• 50-Day Range: $1.44 to $2.30
• 52-Week Range: $1.26 to $5.46
• Volume: 60,311 shs
• Average Volume: 98,191 shs
• Market Capitalization: $62.44 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $8.50
• Consensus Rating: Hold

EDAP TMS Stock Analysis - MarketRank™

EDAP TMS scored higher than 59% of companies evaluated by MarketBeat, and ranked 455th out of 941 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.2 / 5
• Analyst Rating: Hold

Consensus Rating

EDAP TMS has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 1 buy rating, 2 hold ratings, and no sell ratings.

Amount of Analyst Coverage

EDAP TMS has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for EDAP TMS are expected to grow in the coming year, from ($0.60) to ($0.48) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of EDAP TMS is -2.69, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of EDAP TMS is -2.69, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

EDAP TMS has a P/B Ratio of 1.42. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.17% of the float of EDAP TMS has been sold short.

Short Interest Ratio / Days to Cover

EDAP TMS has a short interest ratio ("days to cover") of 0.5, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in EDAP TMS has recently decreased by 29.03%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

EDAP TMS does not currently pay a dividend.

Dividend Growth

EDAP TMS does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

0.17% of the float of EDAP TMS has been sold short.

Short Interest Ratio / Days to Cover

EDAP TMS has a short interest ratio ("days to cover") of 0.5, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in EDAP TMS has recently decreased by 29.03%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 2.2 / 5
• News Sentiment: 0.94

News Sentiment

EDAP TMS has a news sentiment score of 0.94. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for EDAP TMS this week, compared to 2 articles on an average week.

MarketBeat Follows

1 people have added EDAP TMS to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, EDAP TMS insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 0.23% of the stock of EDAP TMS is held by insiders.

Percentage Held by Institutions

62.74% of the stock of EDAP TMS is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

EDAP Stock Analysis - Frequently Asked Questions

How have EDAP shares performed this year?

EDAP TMS's stock was trading at $2.21 at the beginning of 2025. Since then, EDAP stock has decreased by 24.4% and is now trading at $1.67.
View the best growth stocks for 2025 here.

How were EDAP TMS's earnings last quarter?

EDAP TMS S.A. (NASDAQ:EDAP) announced its earnings results on Thursday, May, 15th. The medical equipment provider reported ($0.20) earnings per share for the quarter, missing the consensus estimate of ($0.16) by $0.04. The medical equipment provider earned $16.37 million during the quarter, compared to the consensus estimate of $16.56 million. EDAP TMS had a negative trailing twelve-month return on equity of 51.42% and a negative net margin of 34.45%.
Read the conference call transcript.

Who are EDAP TMS's major shareholders?

EDAP TMS's top institutional investors include Banque Transatlantique SA (1.97%), Scoggin Management LP (0.94%) and Cetera Investment Advisers (0.20%).

How do I buy shares of EDAP TMS?

Shares of EDAP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of EDAP TMS own?

Based on aggregate information from My MarketBeat watchlists, some other companies that EDAP TMS investors own include Energous (WATT), Weatherford International (WFT), CTI BioPharma (CTIC), Petroleo Brasileiro S.A.- Petrobras (PBR), Advanced Micro Devices (AMD), Kandi Technologies Group (KNDI) and NVIDIA (NVDA).

Company Calendar

• Last Earnings: 5/15/2025
• Today: 6/29/2025
• Next Earnings (Estimated): 8/27/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED INSTRUMENTS
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:EDAP
• CIK: 1041934
• Web: www.edap-tms.com
• Phone: (347) 215-3150
• Fax: 33-04-72-15-31-51
• Employees: 230
• Year Founded: 1979

Price Target and Rating

• Average Stock Price Target: $8.50
• High Stock Price Target: $19.00
• Low Stock Price Target: $2.00
• Potential Upside/Downside: +409.0%
• Consensus Rating: Hold
• Rating Score (0-4): 2.33
• Research Coverage: 3 Analysts

Profitability

• EPS (Most Recent Fiscal Year): ($0.62)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$20.58 million
• Net Margins: -34.45%
• Pretax Margin: -33.90%
• Return on Equity: -51.42%
• Return on Assets: -26.43%

Debt

• Debt-to-Equity Ratio: 0.10
• Current Ratio: 1.74
• Quick Ratio: 1.21

Sales & Book Value

• Annual Sales: $69.18 million
• Price / Sales: 0.90
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $1.18 per share
• Price / Book: 1.42

Miscellaneous

• Outstanding Shares: 37,390,000
• Free Float: 37,306,000
• Market Cap: $62.44 million
• Optionable: Optionable
• Beta: 0.01